What is the Taspoglutide?

Taspoglutide is , while it's Molecular Formula is C152H232 N40 O45. Used in Pharmaceutical Industry: Taspoglutide is used as a therapeutic agent for the treatment of type 2 diabetes. It functions by mimicking the action of endogenous GLP-1, which helps in regulating blood glucose levels. The modified structure of Taspoglutide provides a longer-lasting effect, allowing for once-weekly dosing, which can improve patient compliance and quality of life. Used in Clinical Trials: Taspoglutide is used as a subject in phase III clinical trials to evaluate its safety, efficacy, and optimal dosing regimen for the treatment of type 2 diabetes. The trials aim to determine the most effective and safe way to administer Taspoglutide, taking into account its longer duration of action due to the zinc-based preparation. Used in Research and Development: Taspoglutide serves as a valuable compound in the research and development of new treatments for type 2 diabetes. Its modified structure and longer duration of action make it an interesting candidate for further investigation into its potential benefits and possible applications in combination therapies or as a component in novel drug delivery systems.

What is the CAS number for Taspoglutide?

The CAS number of Taspoglutide is 275371-94-3.

What is Taspoglutide (275371-94-3) used for?

Taspoglutide is a glucagon-like peptide-1 (GLP-1) analog with a modified structure that includes -methylalanine, which significantly slows down degradation by DPP-IV and neutral endopeptidase 24.11. This modification enhances its stability and allows for a longer duration of action. Taspoglutide is currently undergoing phase III trials and is administered as a zinc-based preparation, enabling once-weekly injections in the range of 20 to 30 mg.

What is the Taspoglutide?

Taspoglutide is , while it's Molecular Formula is C152H232 N40 O45. Used in Pharmaceutical Industry: Taspoglutide is used as a therapeutic agent for the treatment of type 2 diabetes. It functions by mimicking the action of endogenous GLP-1, which helps in regulating blood glucose levels. The modified structure of Taspoglutide provides a longer-lasting effect, allowing for once-weekly dosing, which can improve patient compliance and quality of life. Used in Clinical Trials: Taspoglutide is used as a subject in phase III clinical trials to evaluate its safety, efficacy, and optimal dosing regimen for the treatment of type 2 diabetes. The trials aim to determine the most effective and safe way to administer Taspoglutide, taking into account its longer duration of action due to the zinc-based preparation. Used in Research and Development: Taspoglutide serves as a valuable compound in the research and development of new treatments for type 2 diabetes. Its modified structure and longer duration of action make it an interesting candidate for further investigation into its potential benefits and possible applications in combination therapies or as a component in novel drug delivery systems.

What is the CAS number for Taspoglutide?

The CAS number of Taspoglutide is 275371-94-3.

What is Taspoglutide (275371-94-3) used for?

Taspoglutide is a glucagon-like peptide-1 (GLP-1) analog with a modified structure that includes -methylalanine, which significantly slows down degradation by DPP-IV and neutral endopeptidase 24.11. This modification enhances its stability and allows for a longer duration of action. Taspoglutide is currently undergoing phase III trials and is administered as a zinc-based preparation, enabling once-weekly injections in the range of 20 to 30 mg.